Hematologic Malignancies Session 2: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasm and Pharmacology (Oncology)

Session 2: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasm and Pharmacology

TOPICS

Welcome | Housekeeping Notes
Robert S. Siegel, MD

Acute Myeloid Leukemia
Richard Stone, MD

Bone Marrow Transplantation
F. Marc Stewart, MD

Myeloproliferative Neoplasms
Ayalew Tefferi, MD

Pharmacology I
Edward Chu, MD, MMS

Lunch Review Session 5: AML, Bone Transplantation, Myeloproliferative Neoplasms and Pharmacology
Course Director and Faculty Panelists

Pharmacology II
Edward Chu, MD, MMS

Pharmacology III
Edward Chu, MD, MMS

Palliative Care
Erica Schockett, MD

Next Gen Sequencing for the Diagnosis and Treatment of Neoplastic Disorders
Howard "Skip" Burris, MD, FACP, FASCO

T Cell Therapies for Cancer
Catherine Bollard, MBChB, MD, FRACP, FRCPA

Closing Remarks | Adjournment 
Robert S. Siegel, MD

Course summary
Course opens: 
09/07/2021
Course expires: 
12/31/2022
Part of: 
2021 Hematology and Oncology Best Practices On Demand - Oncology and Hematologic Malignancies Sessions (5 Days)
Please login or register to take this course.

SESSION INSTRUCTIONS:

Please click the START button to review this session.

After you review/complete this session, please return to the course MAIN page, so you can review/select another session and/or claim your applicable earned CME hours.